Tuesday, 25 September 2012
PHARMAC welcomes new Pharmacology and Therapeutics Advisory Committee (PTAC) chair
PHARMAC is welcoming the appointment of Dr Sisira Jayathissa to the chairmanship of PTAC, says Medical Director Dr Peter Moodie.
Tuesday, 10 July 2012
PHARMAC funds new targeted lung cancer drug
Funded treatment options for New Zealand’s most common form of cancer will take a step forward in August when PHARMAC begins funding gefitinib (Iressa), a targeted treatment for lung cancer.
Tuesday, 29 May 2012
PHARMAC moves to protect babies from whooping cough
PHARMAC will extend funding to a type of antibiotic that can be used to treat and prevent pertussis (whooping cough) in children under one.
Thursday, 15 March 2012
3000 submissions received on diabetes test strips and meters consultation
PHARMAC’s consultation on the proposal to change to a sole supplier of blood glucose testing strips and meters has ended with over 3000 submissions received.
Tuesday, 13 March 2012
End to postcode prescribing for insulin pumps on the horizon
With less than a week remaining, PHARMAC is keen to hear the public’s views on its proposal to fund insulin pumps.
Friday, 2 March 2012
Two new targeted cancer drugs funded in agreement
PHARMAC is funding two new targeted cancer medicines following an agreement with GlaxoSmithKline.
Thursday, 15 December 2011
Investment in medicines highest in PHARMAC history
A surge in the medicines budget over the past three years, combined with PHARMAC’s savings programmes, has seen PHARMAC investing heavily in new medicines.
Friday, 2 December 2011
One Heart Many Lives supporting health and competition at IronMāori
The IronMāori event in Napier on 3 December is serious competition but brings a serious health message too, says PHARMAC’s Māori health manager Marama Parore.
Monday, 31 October 2011
Papers reveal PHARMAC's cautious approach with new anticoagulant drug
Papers released by PHARMAC today outline the careful consideration given before funding was approved for the new-generation anticoagulant drug dabigatran (Pradaxa).
Friday, 30 September 2011
PHARMAC Board strengthens relationship with DHBs
Getting closer to district health boards, on whose behalf PHARMAC aims to spend $777 million this year, took on a new meaning today.
Thursday, 28 July 2011
PHARMAC widens access to two cancer drugs
Cancer treatment has taken another step forward with PHARMAC recently approving wider funding for two cancer treatments.
Monday, 27 June 2011
'More permissive' system follows Exceptional Circumstances review
PHARMAC is moving to a more permissive and streamlined system for assessing people seeking medicines that aren’t funded on the Pharmaceutical Schedule.
Thursday, 23 June 2011
Two new treatments for bone-thinning disease
PHARMAC is funding two new treatments for the bone-thinning disease osteoporosis.
Monday, 20 June 2011
Indigenous Cardiovasular Health conference
A New Zealand preventative health campaign which has significantly improved take-up of cholesterol lowering medication among Maori and Pacific Island males sets the bar for Australia to develop its own initiatives to achieve similar outcomes for Indigenous Australians.
Thursday, 16 June 2011
PHARMAC welcomes PTAC reappointment
PHARMAC is welcoming the reappointment of Waikato Hospital physician Dr Graham Mills to the Pharmacology and Therapeutics Advisory Committee (PTAC).
Tuesday, 14 June 2011
'Game-changing' anti-clotting treatment funded
PHARMAC is funding an innovative form of anti-blood clotting treatment that will significantly change the way anticoagulation is managed in New Zealand.
Monday, 2 May 2011
US trade deal could scuttle Pharmac
Kiwis could be paying more for pharmaceuticals if the Trans Pacific Partnership (TPP) free trade negotiations are successful, the Green Party said today.
Sunday, 1 May 2011
PHARMAC to fund new multiple myeloma treatments
PHARMAC is enabling New Zealanders with multiple myeloma (MM) to benefit from early use of a new treatment, bortezomib (Velcade) as well as providing wider access to thalidomide, another treatment used for MM.
Friday, 29 April 2011
New funded treatment for epilepsy
People with epilepsy will have a new funded treatment from 1 May, when PHARMAC begins funding for lacosamide (Vimpat).
Tuesday, 26 April 2011
PHARMAC to fund sleep disorder treatment
PHARMAC will fund a new treatment for the sleep disorder narcolepsy from 1 May 2011.
Monday, 28 February 2011
PHARMAC reduces paperwork, expands access to Special Foods
Changes in access rules for funded special foods will see more prescribers able to supply funded special foods to patients.
Wednesday, 22 December 2010
Three new members appointed to PHARMAC advisory committee
PHARMAC is welcoming the appointment of three new members to the Pharmacology and Therapeutics Advisory Committee (PTAC).
Wednesday, 15 December 2010
Adaptable approach key to success in hospitals, says PHARMAC CE
Learning from past experience will serve PHARMAC well as it takes a greater role in purchasing hospital medicines, says Chief Executive Matthew Brougham.
Monday, 29 November 2010
Wider access to MS treatments; new drugs in Bayer agreement
Government drug funder PHARMAC will provide wider access to treatments for multiple sclerosis (MS), and fund new blood-thinning and antibiotic treatments following an agreement with Bayer New Zealand Limited.
Thursday, 25 November 2010
Two further treatments for depression to be funded
PHARMAC is adding two further treatments for depression to the Pharmaceutical Schedule from 1 December 2010.
Monday, 22 November 2010
Brain tumour patients to gain greater access to expensive drug
People with brain tumours are to have greater access to an expensive cancer drug from 1 December.
Thursday, 28 October 2010
Agreement seals new kidney cancer, smoking cessation, arthritis treatments
Patients with a form of kidney cancer will have a new treatment option as part of a multi-product agreement between PHARMAC and Pfizer.
Friday, 22 October 2010
New money leads to leap in availability of medicines to NZers
A $40 million lift in pharmaceutical spending has led to a significant rise in the number of medicines available to New Zealanders, and the number of people receiving them.
Thursday, 21 October 2010
PHARMAC launches new tool to help track medicine funding applications
PHARMAC has launched a new online tool that will give people a look inside PHARMAC’s evaluation of medicine funding applications.
Monday, 18 October 2010
Multi-resistant HIV strains prompt new funding
Two newly funded medicines will help the fight against drug-resistant strains of the human immunodeficiency virus (HIV) in a multi-product deal that will also help fight infections in hospitals.